Safe Medications for Anxiety and Sleep Disorders
Cognitive Behavioral Therapy for Insomnia (CBT-I) should be the first-line treatment for both anxiety and sleep disorders, with pharmacological options considered only when CBT-I is unsuccessful or as a temporary adjunct. 1, 2
Non-Pharmacological Approaches (First-Line)
Non-pharmacological approaches should always be prioritized due to their effectiveness and favorable safety profile:
CBT-I components:
Additional non-pharmacological interventions:
Non-pharmacological approaches have been shown to produce equivalent results to sleep medications with no side effects, fewer episodes of relapse, and continued improvement after treatment ends 4. Additionally, these interventions can effectively reduce anxiety symptoms with a moderate effect size (Hedges' g = -0.38) 5.
Pharmacological Options (Second-Line)
When medication becomes necessary after failed CBT-I trials, follow this evidence-based algorithm:
First-Line Medications:
For sleep onset insomnia:
- Zolpidem 10mg (5mg in elderly)
- Eszopiclone 2-3mg (1-2mg in elderly) 2
For sleep maintenance insomnia:
- Low-dose doxepin (3-6mg) - particularly safe option
- Eszopiclone 2-3mg
- Suvorexant 10-20mg 2
Second-Line Medications:
For sleep onset insomnia:
For both sleep onset and maintenance:
- Temazepam 15mg (use with caution) 2
Third-Line Options:
- Sedating antidepressants (when comorbid with depression/anxiety)
- Combined BzRA and sedating antidepressant 1, 2
Medications to Avoid
Several commonly used medications have significant safety concerns:
Not recommended due to insufficient evidence:
Not recommended due to safety concerns:
- Barbiturates and older sedative-hypnotics
- Benzodiazepines in elderly (high risk of falls, cognitive impairment)
- Z-drugs in elderly (risk of falls, confusion, complex sleep behaviors) 2
Use with caution:
Special Considerations
Elderly Patients
- Start with the lowest effective dose
- Use medication for shortest duration necessary (≤4 weeks)
- Consider shorter half-life medications if daytime sedation occurs
- Avoid medications with anticholinergic properties
- Monitor closely for fall risk 2
Safety Monitoring
- Follow patients regularly (every few weeks initially)
- Assess for effectiveness and side effects
- Use lowest effective maintenance dose
- Taper medication when conditions allow
- Be aware that hypnotic drugs may be associated with serious adverse effects including dementia, injury, and fractures 1
Common Pitfalls to Avoid
- Immediate resort to medication - Always try CBT-I first
- Long-term use of sleep medications - FDA approves most only for short-term use (4-5 weeks)
- Ignoring potential for serious adverse effects - Including "sleep driving," behavioral abnormalities, and worsening depression
- Overlooking drug interactions - Many sleep/anxiety medications have significant interaction profiles
- Inadequate follow-up - Regular monitoring is essential for safety and effectiveness
Remember that pharmacological treatment should always be accompanied by patient education regarding treatment goals, safety concerns, potential side effects, and continued use of cognitive and behavioral techniques 1.